Jennifer Mulle, MHS, PhD, is an Associate Professor in the Departments of Psychiatry and Neuroscience and Cell Biology at the Robert Wood Johnson School of Medicine, Rutgers University, and a member of the Rutgers Center for Genomics of Psychiatric Health and Addictions and the Rutgers Brain Health Institute.
Dr. Mulle’s research program aims to understand the developmental progression of schizophrenia and related neurodevelopmental and psychiatric disorders at the molecular, cellular, circuitry, and behavioral scales of analysis. She uses rare genetic variants as models for this area of inquiry with a focus on the schizophrenia-associated 3q29 deletion. Dr. Mulle is the leading expert on the phenotypic spectrum of 3q29 deletion syndrome, and her lab supports the 3q29 registry housed at Rutgers University. She also maintains the 3q29 repository of human 3q29 deletion samples as well as the 3q29 mouse model. Dr. Mulle works closely with the 3q29 deletion stakeholder community on outreach, engagement, and education.
Dr. Mulle earned her MHS in genetic epidemiology at the Johns Hopkins School of Public Health, and her PhD in Human Genetics from the Johns Hopkins School of Medicine. She completed postdoctoral training in the lab of Dr. Steven Warren at Emory University, where she discovered the association of the 3q29 deletion with high risk for schizophrenia.